Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Gastrointestinal Endoscopy|August 4, 2015
Agreement of site and central readings of ileocolonoscopic scores in Crohn's disease: comparison using data from the EXTEND trialPaul Rutgeerts, Walter Reinisch, Jean-Frederic Colombel, et al.
Journal of Crohn'S & Colitis|February 13, 2019
Efficacy and Safety of Adalimumab by Disease Duration: Analysis of Pooled Data From Crohn's Disease StudiesRemo Panaccione, Robert Löfberg, Paul Rutgeerts, et al.
Inflammatory Bowel Diseases|February 13, 2019
Adalimumab Effectiveness Up to Six Years in Adalimumab-naïve Patients with Crohn's Disease: Results of the PYRAMID RegistryEdward V Loftus, Walter Reinisch, Remo Panaccione, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|August 23, 2008
The gastric mucus layers: constituents and regulation of accumulationMia Phillipson, Malin E V Johansson, Johanna Henriksnäs, et al.
Nature Chemical Biology|June 3, 2008
A mammalian functional nitrate reductase that regulates nitrite and nitric oxide homeostasisEmmelie A Jansson, Liyue Huang, Ronny Malkey, et al.
Free Radical Biology & Medicine|May 15, 2009
Gastroprotective and blood pressure lowering effects of dietary nitrate are abolished by an antiseptic mouthwashJoel Petersson, Mattias Carlström, Olof Schreiber, et al.
The American Journal of Gastroenterology|June 6, 2018
Lymphoma Risk and Overall Safety Profile of Adalimumab in Patients With Crohn's Disease With up to 6 Years of Follow-Up in the Pyramid RegistryGeert DʼHaens, Walter Reinisch, Remo Panaccione, et al.
Journal of Crohn'S & Colitis|November 6, 2016
Characterisation of Mucosal Healing with Adalimumab Treatment in Patients with Moderately to Severely Active Crohn's Disease: Results from the EXTEND TrialWalter Reinisch, Jean-Frédéric Colombel, Geert D'Haens, et al.
Pageof 4